ArticleJournal of medicinal chemistry2022

Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions.

Yubai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.